Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tuvusertib (M1774) is an orally available ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor (Ki< 1 µΜ) with selective and potentially antitumor activity.Tuvusertib selectively inhibits ATR activity and blocks downstream phosphorylation of serine/threonine protein kinase checkpoint kinase 1 (CHK1), thereby inhibits DNA damage checkpoint activation, disrupting DNA damage repair and inducing apoptosis in tumor cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $68 | In Stock | |
5 mg | $165 | In Stock | |
10 mg | $257 | In Stock | |
25 mg | $496 | In Stock | |
50 mg | $692 | In Stock | |
100 mg | $979 | In Stock | |
1 mL x 10 mM (in DMSO) | $187 | In Stock |
Description | Tuvusertib (M1774) is an orally available ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor (Ki< 1 µΜ) with selective and potentially antitumor activity.Tuvusertib selectively inhibits ATR activity and blocks downstream phosphorylation of serine/threonine protein kinase checkpoint kinase 1 (CHK1), thereby inhibits DNA damage checkpoint activation, disrupting DNA damage repair and inducing apoptosis in tumor cells. |
Alias | M1774, ATR inhibitor 1 |
Molecular Weight | 370.32 |
Formula | C16H12F2N8O |
Cas No. | 1613200-51-3 |
Smiles | Cn1cncc1-c1c(F)cncc1NC(=O)c1c(N)nn2cc(F)cnc12 |
Relative Density. | 1.68 g/cm3 (Predicted) |
Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 6.25 mg/mL (16.88 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.